Effects of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies on Behavioral Outcomes in East Asians: Statistical Analysis Protocol for a Randomized Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/65012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Harrison Hin Sheung Ho und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong). Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Wearable Electronic Devices. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Evidence suggests that the communication of type 2 diabetes (T2D) genetic risk alone has limited effectiveness on facilitating behavioral changes among individuals of European descent. Although the use of wearable devices has been associated with changes in behavior, the effects of combining personalized precision medicine with wearable devices on behaviors related to T2D prevention remain unclear. This study aims to assess the novel effects of T2D genetic risk communication and wearable device functions on objectively measured moderate to vigorous physical activity (MVPA) time among East Asian individuals with overweight or obesity.
Objective
The objectives of this study are to (1) investigate the effects of communicating T2D genetic risk and (2) examine the effects of combining T2D genetic risk communication with wearable device functions such as step goal setting and activity prompts on objectively measured MVPA time among East Asians with overweight or obesity.
Methods
In this parallel-group randomized controlled trial, 355 East Asians with overweight or obesity aged between 40 and 60 years are allocated to 1 of 3 groups: 1 control and 2 intervention groups. Blood samples are used for estimation of T2D genetic risk and tested for metabolic risk markers. T2D genetic risk is estimated based on 113 single nucleotide polymorphisms associated with T2D among East Asians using an established method. All 3 groups receive a Fitbit device. Both intervention groups will receive T2D genetic risk estimates along with lifestyle advice, but one of the intervention groups will receive additional Fitbit functions: step goal setting and prompt functions. The intervention materials are delivered weekly using WhatsApp and monthly via email. The primary outcome is MVPA time, which is objectively measured with the built-in accelerometer of the Fitbit Inspire 3 and will be assessed at baseline, immediately after the intervention, 12 months after the intervention, and at 6-month follow-up. Secondary outcomes include other parameters, such as sedentary time, BMI, systolic and diastolic blood pressure, 5 metabolic risk markers, handgrip strength, sleep, activity calories, self-reported physical activity, self-reported fruit and vegetable consumption, smoking status, and psychological variables.
Results
This study was funded in January 2023. Data collection for baseline assessments began in February 2023. Formal data analysis started in April 2025 after the 6-month follow-up assessments were completed.
Conclusions
To the best of our knowledge, this study will be the first randomized controlled trial to combine T2D genetic risk communication with wearable device functions in any population. Novel findings will be used to inform future lifestyle modification strategies for T2D. We plan to provide a comprehensive report on this study by publishing this analysis plan before the completion of data collection. Trial Registration ClinicalTrials.gov NCT05524909; https://www.clinicaltrials.gov/study/NCT05524909 International Registered Report Identifier (IRRID) DERR1-10.2196/65012
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).
- Herbert Wertheim School of Public Health & Human Longevity Science, University of California San Diego, La Jolla, CA, United States.
- Exai Bio, Palo Alto, CA, United States.
- School of Arts and Social Sciences, Hong Kong Metropolitan Universit, Hong Kong, China (Hong Kong).
- Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).
- Medical Research Council Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
ORCID-Profile: Harrison Hin Sheung Ho, Ziyuan Chen, Job Godino, Michael Multhaup, Derwin King Chung Chan, Shiu Lun Au Yeung, Shan Luo, Brian Hon Yin Chung, Simon Griffin, Youngwon Kim
Zitieren
APA
Ho, H. H. S., Chen, Z., Godino, J., Multhaup, M., Chan, D. K. C., Au Yeung, S. L., Luo, S., Chung, B. H. Y., Griffin, S., & Kim, Y. (2025). Effects of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies on Behavioral Outcomes in East Asians: Statistical Analysis Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/65012
Vancouver
Ho HHS, Chen Z, Godino J, Multhaup M, Chan DKC, Au Yeung SL, et al. Effects of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies on Behavioral Outcomes in East Asians: Statistical Analysis Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/65012
BibTeX
@article{Ho2025,
author = {Ho, Harrison Hin Sheung and Chen, Ziyuan and Godino, Job and Multhaup, Michael and Chan, Derwin King Chung and Au Yeung, Shiu Lun and Luo, Shan and Chung, Brian Hon Yin and Griffin, Simon and Kim, Youngwon},
title = {Effects of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies on Behavioral Outcomes in East Asians: Statistical Analysis Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/65012}
}
EUVIMED